Back to discover
Drug

Gold

Research stage
Emerging researchRising momentum
Also known as Au - Gold, CI 77480, COLLOIDAL GOLD, Gold flake+4 more

Au - Gold, CI 77480, COLLOIDAL GOLD, Gold flake, Gold leaf, Gold powder, Gold, colloidal, Gold, elemental.

5
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection.

Research2024-02-17International journal of molecular sciences

Smart nanoparticles for cancer therapy.

Research2023-11-03Signal transduction and targeted therapy

Nanoparticles in Medicine: Current Status in Cancer Treatment.

Research2023-08-15International journal of molecular sciences

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Gold
Aliases & brands
Au - GoldCI 77480COLLOIDAL GOLDGold flakeGold leafGold powderGold, colloidalGold, elemental
RxNorm CUI
1311190
ChEMBL ID
CHEMBL3137693
UNII
79Y1949PYO

Research activity

5 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20202024
Most influential

Smart nanoparticles for cancer therapy.

Signal transduction and targeted therapy · 2023 · 474 cites

Nanoparticles in Medicine: Current Status in Cancer Treatment.

International journal of molecular sciences · 2023 · 36 cites

Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection.

International journal of molecular sciences · 2024 · 31 cites
Recent papers

Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection.

International journal of molecular sciences · 2024 · 31 cites

Smart nanoparticles for cancer therapy.

Signal transduction and targeted therapy · 2023 · 474 cites

Nanoparticles in Medicine: Current Status in Cancer Treatment.

International journal of molecular sciences · 2023 · 36 cites
Major research themes8
Metal Nanoparticles3Nanotubes, Carbon2Neoplasms2Alzheimer Disease1Cell Survival1Chemistry Techniques, Synthetic1Hydrogels1Medicine1
Journals, researchers & institutions
Top journals
  • International journal of molecular sciences2
  • ACS biomaterials science & engineering1
  • International journal of nanomedicine1
  • Signal transduction and targeted therapy1
Leading researchers
  • Agaj A1
  • Aguilar LC1
  • Amina SJ1
  • Bulog A1
  • Cai L1
  • Chiang MC1
  • Čolić M1
  • Duc D1
Leading institutions
free-text, unnormalised
  • ARC Centre of Excellence for Electromaterials Science1
  • Atta-ur-Rahman School of Applied Biosciences (ASAB)1
  • Cancer Research Institute1
  • College of Science and Engineering1
  • General Hospital Pula1
  • Iverson Health Innovation Research Institute1

Related diseases

1 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Active research areas

Related drugs

3 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across the same disease area as Gold in the shared literature.

1 shared disease1 shared paper

Studied across the same disease area as Gold in the shared literature.

1 shared disease1 shared paper

Frequently co-studied with Gold in the research literature.

1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature